• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追踪髓系来源的抑制性细胞在原发性乳腺肿瘤微环境中的命运。

Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment.

机构信息

Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.

出版信息

PLoS One. 2018 Apr 20;13(4):e0196040. doi: 10.1371/journal.pone.0196040. eCollection 2018.

DOI:10.1371/journal.pone.0196040
PMID:29677215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5909918/
Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid progenitor cells that are expanded in cancer and act as potent suppressors of the anti-tumor immune response. MDSCs consist of two major subsets, namely monocytic (M-) MDSCs and granulocytic (G-) MDSCs that differ with respect to their phenotype, morphology and mechanisms of suppression. Here, we cultured bone marrow cells with IL-6 and GM-CSF in vitro to generate a population of bone marrow MDSCs (BM-MDSCs) similar to G-MDSCs from tumor-bearing mice in regards to phenotype, morphology and suppressive-function. Through fluorescent labeling of these BM-MDSCs and optical imaging, we could visualize the recruitment and localization of BM-MDSCs in breast tumor-bearing mice in vivo. Furthermore, we were able to demonstrate that BM-MDSCs home to primary and metastatic breast tumors, but have no significant effect on tumor growth or progression. Ex vivo flow cytometry characterization of BM-MDSCs after adoptive transfer demonstrated both organ-and tumor-specific effects on their phenotype and differentiation, demonstrating the importance of the local microenvironment on MDSC fate and function. In this study, we have developed a method to generate, visualize and detect BM-MDSCs in vivo and ex vivo through optical imaging and flow cytometry, in order to understand the organ-specific changes rendered to MDSCs in breast cancer.

摘要

髓系来源的抑制细胞(MDSCs)是一种异质性的未成熟髓系祖细胞群体,在癌症中扩增,并作为抗肿瘤免疫反应的有效抑制物。MDSCs 由两个主要亚群组成,即单核细胞(M-)MDSCs 和粒细胞(G-)MDSCs,它们在表型、形态和抑制机制方面存在差异。在这里,我们通过体外培养骨髓细胞与 IL-6 和 GM-CSF,生成了一群类似于荷瘤小鼠来源的 G-MDSCs 的骨髓 MDSCs(BM-MDSCs),在表型、形态和抑制功能方面都相似。通过对这些 BM-MDSCs 进行荧光标记和光学成像,我们可以在体内可视化 BM-MDSCs 在乳腺癌荷瘤小鼠中的募集和定位。此外,我们还能够证明 BM-MDSCs 归巢到原发性和转移性乳腺癌肿瘤,但对肿瘤生长或进展没有显著影响。过继转移后对 BM-MDSCs 的体外流式细胞术特征分析表明,它们的表型和分化具有器官和肿瘤特异性效应,这表明局部微环境对 MDSC 命运和功能的重要性。在这项研究中,我们开发了一种通过光学成像和流式细胞术在体内和体外生成、可视化和检测 BM-MDSCs 的方法,以了解乳腺癌中 MDSCs 所呈现的器官特异性变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/e0b202d2521b/pone.0196040.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/3a06acd2f836/pone.0196040.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/4ea333444337/pone.0196040.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/1a41eee7c49e/pone.0196040.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/7d1c83dd7d2b/pone.0196040.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/ed428c85ed0d/pone.0196040.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/e0b202d2521b/pone.0196040.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/3a06acd2f836/pone.0196040.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/4ea333444337/pone.0196040.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/1a41eee7c49e/pone.0196040.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/7d1c83dd7d2b/pone.0196040.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/ed428c85ed0d/pone.0196040.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844d/5909918/e0b202d2521b/pone.0196040.g006.jpg

相似文献

1
Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment.追踪髓系来源的抑制性细胞在原发性乳腺肿瘤微环境中的命运。
PLoS One. 2018 Apr 20;13(4):e0196040. doi: 10.1371/journal.pone.0196040. eCollection 2018.
2
Visualization and quantification of homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.可视化和量化髓源性抑制细胞在原发性和转移性癌症中的归巢动力学。
Theranostics. 2019 Aug 12;9(20):5869-5885. doi: 10.7150/thno.33275. eCollection 2019.
3
Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.体外从小鼠骨髓生成的髓源性抑制细胞对蛋白聚糖诱导的自身免疫性关节炎的抑制作用
PLoS One. 2014 Nov 4;9(11):e111815. doi: 10.1371/journal.pone.0111815. eCollection 2014.
4
[Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].[重组高迁移率族蛋白B1在体外诱导小鼠髓系细胞分化为髓源性抑制细胞]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Oct;32(10):1362-1365.
5
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.干扰素调节因子 4(IRF4)控制髓系来源的抑制细胞(MDSC)分化和功能。
J Leukoc Biol. 2016 Dec;100(6):1273-1284. doi: 10.1189/jlb.1A0215-068RR. Epub 2016 Sep 6.
6
Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.肿瘤条件诱导骨髓中粒细胞而非单核细胞的免疫抑制性白细胞扩增,并增加小鼠 CXCR2 的表达。
Eur J Immunol. 2018 Mar;48(3):532-542. doi: 10.1002/eji.201746976. Epub 2017 Dec 8.
7
Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.地塞米松诱导的髓源性抑制细胞通过 iNOS 和糖皮质激素受体依赖的机制延长同种异体心脏移植物的存活。
Front Immunol. 2018 Feb 15;9:282. doi: 10.3389/fimmu.2018.00282. eCollection 2018.
8
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.髓源性抑制细胞通过 IL-7 和 STAT5 抑制肺癌中的 B 细胞反应。
J Immunol. 2018 Jul 1;201(1):278-295. doi: 10.4049/jimmunol.1701069. Epub 2018 May 11.
9
Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.地西他滨通过耗尽骨髓瘤微环境中的单核细胞髓系来源抑制细胞发挥强大的抗骨髓瘤活性。
J Cancer Res Clin Oncol. 2019 Feb;145(2):329-336. doi: 10.1007/s00432-018-2790-6. Epub 2018 Nov 13.
10
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.靶向髓源抑制性细胞联合原发性乳腺肿瘤切除术可减少肺部转移生长。
Breast Cancer Res. 2019 Sep 5;21(1):103. doi: 10.1186/s13058-019-1189-x.

引用本文的文献

1
Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy.利用纳米材料调控免疫微环境:肿瘤免疫治疗的新策略。
Front Immunol. 2025 Jul 2;16:1614640. doi: 10.3389/fimmu.2025.1614640. eCollection 2025.
2
A Complex Interplay of Tumor Microenvironment Could Enhance Cholangiocarcinoma Progression Even After Surgery: A Prospective Study.肿瘤微环境的复杂相互作用即使在手术后也可能促进胆管癌进展:一项前瞻性研究
J Clin Med Res. 2024 Aug;16(7-8):363-374. doi: 10.14740/jocmr5201. Epub 2024 Jul 23.
3
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).

本文引用的文献

1
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.肿瘤微环境中髓源性抑制细胞的本质
Trends Immunol. 2016 Mar;37(3):208-220. doi: 10.1016/j.it.2016.01.004. Epub 2016 Feb 6.
2
64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.用64Cu标记靶向T细胞受体的抗体并随后进行内化,可通过正电子发射断层扫描(PET)在体内追踪淋巴细胞。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1161-6. doi: 10.1073/pnas.1418391112. Epub 2015 Jan 13.
3
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.
髓源性抑制细胞作为新兴疗法和纳米疗法的靶点(综述)
Med Int (Lond). 2024 Jun 25;4(5):46. doi: 10.3892/mi.2024.170. eCollection 2024 Sep-Oct.
4
Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export.外排蛋白 1 通过 ERK1/2 核输出来调控肿瘤中髓源性抑制细胞的免疫抑制功能。
Cell Mol Immunol. 2024 Aug;21(8):873-891. doi: 10.1038/s41423-024-01187-1. Epub 2024 Jun 20.
5
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment.转移的守护者和调解者:探索乳腺癌微环境中的 T 淋巴细胞、髓源性抑制细胞和肿瘤相关巨噬细胞。
Int J Mol Sci. 2024 Jun 5;25(11):6224. doi: 10.3390/ijms25116224.
6
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.
7
MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.乳腺癌中的 MDSCs:肿瘤进展的重要促进因素和新兴治疗靶点。
Front Immunol. 2023 Jul 3;14:1199273. doi: 10.3389/fimmu.2023.1199273. eCollection 2023.
8
Role of tumor microenvironment in cancer progression and therapeutic strategy.肿瘤微环境在癌症进展和治疗策略中的作用。
Cancer Med. 2023 May;12(10):11149-11165. doi: 10.1002/cam4.5698. Epub 2023 Feb 21.
9
Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation.用于靶向激活天然免疫细胞的荧光纳米金刚石的抗体偶联
ACS Appl Nano Mater. 2021 Mar 26;4(3):3122-3139. doi: 10.1021/acsanm.1c00256. Epub 2021 Mar 11.
10
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.沉默 STAT3 和激活 TLR7/8 通路重极化并抑制乳腺癌患者来源的髓系抑制细胞。
Front Immunol. 2021 Feb 19;11:613215. doi: 10.3389/fimmu.2020.613215. eCollection 2020.
在荷瘤小鼠中生成一种新的治疗性肽,以消耗髓源性抑制细胞。
Nat Med. 2014 Jun;20(6):676-81. doi: 10.1038/nm.3560. Epub 2014 May 25.
4
The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells.肿瘤微环境塑造浸润性髓系细胞的谱系、转录和功能多样性。
Cancer Immunol Res. 2014 Jul;2(7):655-67. doi: 10.1158/2326-6066.CIR-13-0209. Epub 2014 Mar 31.
5
Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.肿瘤相关调节性树突状细胞的起源与药理学调节。
Int J Cancer. 2014 Jun 1;134(11):2633-45. doi: 10.1002/ijc.28590. Epub 2014 Jan 20.
6
In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.通过正电子发射断层扫描(PET)对体内Th1细胞进行追踪,可揭示其在淋巴组织中的定量和时间分布以及特异性归巢。
J Nucl Med. 2014 Feb;55(2):301-7. doi: 10.2967/jnumed.113.126318. Epub 2014 Jan 16.
7
History of myeloid-derived suppressor cells.髓系来源的抑制性细胞的历史。
Nat Rev Cancer. 2013 Oct;13(10):739-52. doi: 10.1038/nrc3581.
8
Tracking immune cells in vivo using magnetic resonance imaging.利用磁共振成像技术在体内追踪免疫细胞。
Nat Rev Immunol. 2013 Oct;13(10):755-63. doi: 10.1038/nri3531. Epub 2013 Sep 10.
9
The pre-metastatic niche: finding common ground.转移前生态位:寻找共同点。
Cancer Metastasis Rev. 2013 Dec;32(3-4):449-64. doi: 10.1007/s10555-013-9420-1.
10
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.广泛期小细胞肺癌患者骨髓源性抑制细胞的治疗调节及对癌症疫苗免疫反应。
Cancer Immunol Immunother. 2013 May;62(5):909-18. doi: 10.1007/s00262-013-1396-8. Epub 2013 Apr 16.